References
- Hotopf M, Levis G, Normand C. Are SSRIs a cost-effective alternative to tricyclic?. British Journal of Psychiatry 1996; 168: 404–409
- Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal Psychiatry 1997; 170: 120–12X
- Woods S W, Baker C B. Cost-effectiveness of newer antidepressants. Current Opinion in Psychiatry 1997; 10: 905–101X
- Diagnostic and statistical manual of mental disorders. 3rd ed., revised (DSM-IIIR). American Psychiatric Association, 1987, Washington, DC
- Bech P, Kastrup M, Rafaelsen O J. Mini-compendium of rating scale for states of anxiety, depression, mania and schizophrenia with corresponding DSM–III syndrome. Acta Psychiatrica Scandinavica 1986, Suppl.: 326
- Wood S W, Rizzo J A. Cost-effectiveness of antidepressant treatment reassessed. British Journal of Psychiatry 1997; 170: 257–263